Literature DB >> 21606951

TLR-induced activation of Btk -- role for endosomal MHC class II molecules revealed.

Joan Ní Gabhann1, Caroline A Jefferies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21606951      PMCID： PMC3193487          DOI： 10.1038/cr.2011.88

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  12 in total

1.  Bruton's tyrosine kinase is activated upon CD40 stimulation in human B lymphocytes.

Authors:  Cornelia Brunner; Andris Avots; Hans Wolfgang Kreth; Edgar Serfling; Volker Schuster
Journal:  Immunobiology       Date:  2002-10       Impact factor: 3.144

2.  Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4.

Authors:  Caroline A Jefferies; Sarah Doyle; Cornelia Brunner; Aisling Dunne; Elizabeth Brint; Claudia Wietek; Eva Walch; Thomas Wirth; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

Review 3.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

4.  Dendritic cell activation prevents MHC class II ubiquitination and promotes MHC class II survival regardless of the activation stimulus.

Authors:  Even Walseng; Kazuyuki Furuta; Romina S Goldszmid; Karis A Weih; Alan Sher; Paul A Roche
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

5.  Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide.

Authors:  Sarah L Doyle; Caroline A Jefferies; Luke A O'Neill
Journal:  J Biol Chem       Date:  2005-04-22       Impact factor: 5.157

6.  Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk.

Authors:  Xingguang Liu; Zhenzhen Zhan; Dong Li; Li Xu; Feng Ma; Peng Zhang; Hangping Yao; Xuetao Cao
Journal:  Nat Immunol       Date:  2011-03-27       Impact factor: 25.606

7.  TLR signaling and effector functions are intact in XLA neutrophils.

Authors:  Thomas U Marron; Kaileen Rohr; Monica Martinez-Gallo; Joyce Yu; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2010-07-14       Impact factor: 3.969

8.  Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production.

Authors:  Nicole J Horwood; Theresa H Page; John P McDaid; Christine D Palmer; Jamie Campbell; Tara Mahon; Fionula M Brennan; David Webster; Brian M J Foxwell
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

9.  MHC class II molecules enhance Toll-like receptor mediated innate immune responses.

Authors:  Remo Frei; Johanna Steinle; Thomas Birchler; Susanne Loeliger; Caroline Roduit; Dirk Steinhoff; Reinhart Seibl; Katja Büchner; Reinhard Seger; Walter Reith; Roger P Lauener
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

10.  Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity.

Authors:  Tomohiro Kubo; Yuki Uchida; Yuko Watanabe; Masahiro Abe; Akira Nakamura; Masao Ono; Shizuo Akira; Toshiyuki Takai
Journal:  J Exp Med       Date:  2009-08-17       Impact factor: 14.307
View more
  7 in total

1.  Tollip-induced down-regulation of MARCH1.

Authors:  Marie-Claude Bourgeois-Daigneault; Abdul Mohammad Pezeshki; Tristan Galbas; Mathieu Houde; Martin Baril; Klaus Früh; Abdelaziz Amrani; Satoshi Ishido; Daniel Lamarre; Jacques Thibodeau
Journal:  Results Immunol       Date:  2013-02-20

2.  Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk.

Authors:  Mingye Feng; James Y Chen; Rachel Weissman-Tsukamoto; Jens-Peter Volkmer; Po Yi Ho; Kelly M McKenna; Samuel Cheshier; Michael Zhang; Nan Guo; Phung Gip; Siddhartha S Mitra; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

3.  Knockout of Bruton's tyrosine kinase in macrophages attenuates diabetic nephropathy in streptozotocin-induced mice.

Authors:  Zhe Fan; Yuanyuan Li; Lingling Xia; Yonggui Wu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

4.  Therapeutic inhibition of pro-inflammatory signaling and toxicity to staphylococcal enterotoxin B by a synthetic dimeric BB-loop mimetic of MyD88.

Authors:  Teri L Kissner; Gordon Ruthel; Shahabuddin Alam; Enrique Mann; Dariush Ajami; Mitra Rebek; Eileen Larkin; Stefan Fernandez; Robert G Ulrich; Sun Ping; David S Waugh; Julius Rebek; Kamal U Saikh
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

Review 5.  Targeting tumour microenvironment by tyrosine kinase inhibitor.

Authors:  Hor-Yue Tan; Ning Wang; Wing Lam; Wei Guo; Yibin Feng; Yung-Chi Cheng
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

6.  Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus.

Authors:  Samantha A Chalmers; Jing Wen; Jessica Doerner; Ariel Stock; Carla M Cuda; Hadijat M Makinde; Harris Perlman; Todd Bosanac; Deborah Webb; Gerald Nabozny; Jay S Fine; Elliott Klein; Meera Ramanujam; Chaim Putterman
Journal:  Arthritis Res Ther       Date:  2018-01-25       Impact factor: 5.156

Review 7.  Molecular and Cellular Mechanisms Influenced by Postbiotics.

Authors:  Rafał Jastrząb; Damian Graczyk; Pawel Siedlecki
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.